NASDAQ · Biotechnology

LakeShore Biopharma Co., Ltd (LSB) Stock

$0.63 +0.00% NASDAQ: LSB Healthcare

LakeShore Biopharma Co., Ltd is a biopharmaceutical firm focused on the discovery, advancement, manufacturing, and marketing of vaccines and therapeutic biologics. Its primary targets are infectious diseases and various forms of cancer.

Valuation

MetricValue
Price$0.63
Market Cap$25.84M
P/E Ratio-4.51
P/B Ratio0.91
P/S Ratio0.28
EPS (TTM)$-0.94
52-Week High$8.60
52-Week Low$0.57
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-18.43%
ROA-7.31%
ROCE-15.89%
Gross Margin82.47%
Operating Margin-14.03%
Net Margin-16.26%
Debt/Equity0.83
Current Ratio1.02

Annual Financials (USD)

Metric20212022202320242025
Revenue$257.0M$503.0M$687.0M$573.0M$615.0M
Operating Profit$-126.0M$-119.0M$-139.0M$-446.0M$-86.0M
Net Profit$-192.0M$-237.0M$-145.0M$-433.0M$-100.0M
EPS$-6.67$-0.02$-1.88$-4.05$-0.94
Op Margin-49.0%-23.6%-20.3%-77.8%-14.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$201.0M$1.7B$1.5B$1.4B
Total Liabilities$0$20.0M$991.0M$928.0M$868.0M
Cash$390.0M$271.0M$370.0M$246.0M$28.0M
Borrowings$19.0M$381.0M$499.0M$424.0M$414.0M

Latest News

Lsb Industries Q2 Earnings Call Highlights MarketBeat · Jul 31, 2026 LSB Industries Inc (LXU) (Q2 2026) Earnings Call Highlights: Record Adjusted EBITDA and ... GuruFocus.com · Jul 30, 2026 LSB Industries, Inc. Q2 2026 Earnings Call Summary Moby · Jul 30, 2026 LSB: Q2 Earnings Snapshot Associated Press · Jul 29, 2026 LSB Industries, Inc. Reports Operating Results for the 2026 Second Quarter Business Wire · Jul 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-247.0M$-1.0M$-182.0M$-295.0M$-121.0M
Investing Cash Flow$-209.0M$-598.0M$-114.0M$-89.0M$-35.0M
Financing Cash Flow$0$0$217.0M$0$0
Net Cash Flow$388.0M$-119.0M$99.0M$-124.0M$-139.0M
Free Cash Flow$-351.0M$-300.0M$-240.0M$-339.0M$-139.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.05
EV / EBITDA-11.56
FCF Yield-79.38%
Quick Ratio0.75
Interest Coverage-5.48
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALLKAllakos Inc. $0.33 +0.22% -0.25 $29.74M 0.00%
ANPCAnPac Bio-Medical Science Co., Ltd. $4.30 -3.15% -0.54 $26.97M 0.00%
ELEVElevation Oncology, Inc. $0.37 -2.12% -0.47 $21.63M 0.00%
FRLNFreeline Therapeutics Holdings plc $6.49 +0.15% -0.29 $28.28M 0.00%
GMTXGemini Therapeutics, Inc. $1.35 +0.00% -0.22 $25.49M 0.00%

About LakeShore Biopharma Co., Ltd

LakeShore Biopharma Co., Ltd is a biopharmaceutical firm focused on the discovery, advancement, manufacturing, and marketing of vaccines and therapeutic biologics. Its primary targets are infectious diseases and various forms of cancer. At the core of its innovation is a proprietary PIKA immunomodulating technology platform, which underpins its product pipeline, featuring a PIKA rabies vaccine, a PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. The company maintains an international presence, conducting operations across China, the United States, Singapore, the United Arab Emirates, and the Philippines. Originally founded in 2002 and based in Beijing, China, the entity was known as YS Biopharma Co., Ltd until it officially changed its name to LakeShore Biopharma Co., Ltd in May 2024.

LakeShore Biopharma Co., Ltd is headquartered in CN.

LakeShore Biopharma Co., Ltd (LSB) stock trades at $0.63 with a market capitalization of $25.84M. The stock is valued at a price-to-earnings (P/E) ratio of -4.51, price-to-book of 0.91, price-to-sales of 0.28. Over the past 52 weeks the stock has ranged between $0.57 and $8.60, and currently trades 92.7% below its 52-week high.

On profitability, LakeShore Biopharma Co., Ltd generates a return on equity (ROE) of -18.43%, return on capital employed of -15.89%, an operating margin of -14.03%, a net profit margin of -16.26%.

Official website: www.ysbiopharm.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides